TMCI - Treace Medical Concepts, Inc. Stock Price and Quote

TMCI [NASD]

Index	-	P/E	-	EPS (ttm)	-0.78	Insider Own	17.30%	Shs Outstand	55.54M	Perf Week	2.57%
Market Cap	1.47B	Forward P/E	-	EPS next Y	-0.56	Insider Trans	-11.95%	Shs Float	33.56M	Perf Month	7.99%
Income	-42.80M	PEG	-	EPS next Q	-0.23	Inst Own	48.10%	Short Float / Ratio	3.06% / 2.63	Perf Quarter	0.64%
Sales	141.80M	P/S	10.37	EPS this Y	-80.70%	Inst Trans	10.75%	Short Interest	1.03M	Perf Half Y	3.38%
Book/sh	1.09	P/B	21.59	EPS next Y	26.30%	ROA	-27.60%	Target Price	29.75	Perf Year	17.77%
Cash/sh	1.30	P/C	18.09	EPS next 5Y	-	ROE	-60.90%	52W Range	12.48 - 26.50	Perf YTD	2.35%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-35.00%	52W High	-11.21%	Beta	-
Dividend %	-	Quick Ratio	3.80	Sales past 5Y	-	Gross Margin	80.60%	52W Low	88.54%	ATR	1.16
Employees	423	Current Ratio	4.40	Sales Q/Q	49.10%	Oper. Margin	-27.90%	RSI (14)	55.04	Volatility	3.65% 4.65%
Optionable	Yes	Debt/Eq	0.87	EPS Q/Q	35.40%	Profit Margin	-30.20%	Rel Volume	0.00	Prev Close	23.53
Shortable	Yes	LT Debt/Eq	0.87	Earnings	Mar 07 AMC	Payout	-	Avg Volume	390.95K	Price	23.53
Recom	1.50	SMA20	5.19%	SMA50	1.10%	SMA200	11.34%	Volume	0	Change	0.00%

May-12-22

Initiated

BTIG Research

Buy

$22

Jan-07-22

Upgrade

Morgan Stanley

Equal-Weight → Overweight

$30

May-18-21

Initiated

SVB Leerink

Outperform

$38

May-18-21

Initiated

Stifel

Buy

$35

May-18-21

Initiated

Morgan Stanley

Equal-Weight

$30

May-18-21

Initiated

JP Morgan

Overweight

$37

Mar-14-23 02:11PM	'Dodged a bullet': How fall of SVB is affecting First Coast companies American City Business Journals
Mar-08-23 03:50PM	Why Treace Medical Concepts' Shares Rose Wednesday Motley Fool +21.11%
08:12AM	Q4 2022 Treace Medical Concepts Inc Earnings Call Thomson Reuters StreetEvents
02:07AM	Ponte Vedra-based Treace posts $4.4M loss for Q4, beating analysts expectations American City Business Journals
Mar-07-23 04:05PM	Treace Medical Concepts Reports Fourth Quarter and Full Year 2022 Financial Results GlobeNewswire
09:03AM	Loading…
Mar-03-23 09:03AM	Treace Medical Announces Settlement of Lawsuit Against Fusion Orthopedics GlobeNewswire
09:03AM	Treace Medical Announces Settlement of Lawsuit Again Fusion Orthopedics GlobeNewswire
Feb-27-23 04:15PM	Treace to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023 GlobeNewswire
Feb-09-23 01:00PM	Treace Presents Updated ALIGN3D Interim Data and Latest Product Innovations at the 2023 ACFAS Annual Conference GlobeNewswire
Feb-07-23 09:15PM	Treace Medical Concepts, Inc. Announces Pricing of $100.0 Million Public Offering of Common Stock GlobeNewswire
04:30PM	Treace Medical Concepts, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Jan-31-23 05:09AM	Despite currently being unprofitable, Treace Medical Concepts (NASDAQ:TMCI) has delivered a 25% return to shareholders over 1 year Simply Wall St.
Jan-09-23 08:00AM	Treace Medical Concepts Provides 2022 Preliminary Unaudited Revenue GlobeNewswire
Dec-21-22 05:52AM	Owning 47% shares,institutional owners seem interested in Treace Medical Concepts, Inc. (NASDAQ:TMCI), Simply Wall St.
Dec-20-22 04:15PM	Treace to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 GlobeNewswire
04:15PM	Loading…
Dec-19-22 04:15PM	Treace Medical Announces Expansion of Its Global IP Portfolio with the Grant of Two New U.S. Patents GlobeNewswire
08:50AM	Recent Price Trend in Treace Medical Concepts (TMCI) is Your Friend, Here's Why Zacks
Dec-01-22 08:50AM	Treace Medical Concepts (TMCI) is on the Move, Here's Why the Trend Could be Sustainable Zacks +6.57%
Nov-28-22 04:15PM	Treace Receives FDA 510(k) Clearance for SpeedPlate Rapid Compression Implant Technology GlobeNewswire
Nov-21-22 04:15PM	Treace Announces First Patient Treated in MTA3D Adductoplasty® Clinical Study GlobeNewswire
Nov-14-22 08:50AM	Here's What Could Help Treace Medical Concepts (TMCI) Maintain Its Recent Price Strength Zacks
Nov-10-22 05:50AM	Treace Medical Concepts Third Quarter 2022 Earnings: Beats Expectations Simply Wall St. +10.06%
Nov-08-22 07:15PM	Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM	Treace Medical Concepts Reports Third Quarter 2022 Financial Results GlobeNewswire
Oct-29-22 09:10AM	Bullish insiders at Treace Medical Concepts, Inc. (NASDAQ:TMCI) loaded up on US$1.3m of stock earlier this year Simply Wall St.
Oct-25-22 04:15PM	Treace Announces Participation in Upcoming Investor Conferences GlobeNewswire
Oct-18-22 04:15PM	Treace to Report Third Quarter 2022 Financial Results on November 8, 2022 GlobeNewswire +5.16%
Sep-27-22 04:15PM	Treace Medical Concepts Appoints New Directors GlobeNewswire
Sep-14-22 08:06AM	Treace Medical Shares Interim Data From Corrective Toe Surgery Trial Benzinga +8.28%
Sep-13-22 04:15PM	Treace Highlights New Product Innovations at the 2022 AOFAS Scientific Conference GlobeNewswire
04:05PM	Loading…
04:05PM	Treace Announces Updated ALIGN3D Data at the 2022 AOFAS Annual Meeting GlobeNewswire
Sep-12-22 10:38AM	Strength Seen in Treace Medical Concepts (TMCI): Can Its 8.4% Jump Turn into More Strength? Zacks
Aug-24-22 04:15PM	Treace Announces Participation in the Morgan Stanley 20th Annual Global Healthcare Conference GlobeNewswire +5.32%
Aug-13-22 08:31AM	Earnings Update: Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts Simply Wall St.
Aug-09-22 10:00PM	Treace Medical Concepts, Inc. (TMCI) Q2 2022 Earnings Call Transcript Motley Fool -5.78%
09:44PM	Treace Medical posts $17 million loss as expenses and sales surge American City Business Journals
06:55PM	Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM	Treace Medical Concepts Reports Second Quarter 2022 Financial Results GlobeNewswire
Aug-03-22 04:15PM	Treace Announces Full Commercial Release of New Technologies for Bunion and Related Midfoot Surgery GlobeNewswire +5.30%
Jul-25-22 04:30PM	Treace to Host Surgeon Advisor Event on September 20, 2022 GlobeNewswire
Jul-22-22 08:30AM	Treace to Report Second Quarter 2022 Financial Results on August 9, 2022 GlobeNewswire
Jul-18-22 07:45AM	Sensus Healthcare, Inc. (SRTS) Soars 8.7%: Is Further Upside Left in the Stock? Zacks -5.16%
Jul-05-22 01:12AM	As stocks plunge, Jacksonville public companies have dismal first half of the year American City Business Journals
Jun-28-22 06:37AM	What Type Of Shareholders Make Up Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Share Registry? Simply Wall St.
Jun-20-22 07:48AM	Treace Medical Concepts (TMCI) Moves 8.2% Higher: Will This Strength Last? Zacks
Jun-16-22 02:03PM	On verge of moving into a bigger headquarters, here's how Treace Medical is pursuing growth American City Business Journals -7.55%
May-22-22 08:31AM	Mark Hair Is The Chief Financial Officer of Treace Medical Concepts, Inc. (NASDAQ:TMCI) And They Just Picked Up 46% More Shares Simply Wall St.
May-19-22 11:01AM	Loss-making Treace Medical Concepts (NASDAQ:TMCI) has seen earnings and shareholder returns follow the same downward trajectory over past -51% Simply Wall St.
May-06-22 09:01AM	Treace Medical Concepts, Inc. (TMCI) Q1 2022 Earnings Call Transcript Motley Fool -9.38%
May-05-22 06:25PM	Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates Zacks -5.56%
05:51PM	Treace Medical posts $9 million loss as expenses outpace sales American City Business Journals
04:05PM	Treace Medical Concepts Reports First Quarter 2022 Financial Results GlobeNewswire
08:15AM	Treace Announces Peer-Reviewed Publication of ALIGN3D Multicenter Prospective Clinical Data GlobeNewswire
May-02-22 08:00AM	Treace Secures Up to $150 Million in Debt Financing GlobeNewswire
Apr-14-22 04:15PM	Treace to Report First Quarter 2022 Financial Results on May 5, 2022 GlobeNewswire
Mar-28-22 04:15PM	Treace Files Patent Infringement Suit To Protect Lapiplasty® Bunion Technology GlobeNewswire
Mar-04-22 12:00AM	Treace Medical Concepts, Inc. (TMCI) Q4 2021 Earnings Call Transcript Motley Fool
Mar-03-22 04:05PM	Treace Medical Concepts Reports Fourth Quarter and Full Year 2021 Financial Results GlobeNewswire
Feb-25-22 12:15PM	Treace Announces Updated ALIGN3D Data at the 2022 ACFAS Scientific Conference GlobeNewswire
Feb-23-22 04:15PM	Treace Highlights New Product Innovations at the 2022 ACFAS Scientific Conference GlobeNewswire
Feb-14-22 04:15PM	Treace to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022 GlobeNewswire
Feb-08-22 02:38PM	Fwl Investment Management, Llc Buys E2open Parent Holdings Inc, Cheniere Energy Inc, SPDR ... GuruFocus.com
Feb-01-22 04:15PM	Treace to Announce Latest ALIGN3D Data at the 2022 ACFAS Scientific Conference GlobeNewswire
Jan-28-22 01:38PM	Roubaix Capital, LLC Buys Treace Medical Concepts Inc, Alpha Teknova Inc, EnerSys, Sells Rogers ... GuruFocus.com
Jan-19-22 04:15PM	Treace Announces Grant of U.S. Patent on Instrumented Bunion Correction GlobeNewswire
09:22AM	Here's What Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Shareholder Ownership Structure Looks Like Simply Wall St.
Jan-10-22 07:00AM	Treace Medical Concepts Provides 2021 Preliminary Sales Results GlobeNewswire +14.86%
Jan-07-22 08:00AM	Treace to Present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 GlobeNewswire
Dec-28-21 09:15AM	Treace Medical Concepts Inc (TMCI) CEO John T. Treace Sold $1.4 million of Shares GuruFocus.com
Dec-23-21 09:15AM	Treace Medical Concepts Inc (TMCI) CEO John T. Treace Sold $966,710 of Shares GuruFocus.com
Nov-30-21 04:15PM	Treace Announces Grant of U.S. Patent and Allowance of U.S. Patent Application on Bone Positioner Technology for Bunion Correction GlobeNewswire
Nov-18-21 10:31AM	Treace Medical Concepts Insider Trades $1.5M In Company Stock Benzinga
Nov-15-21 11:39AM	Notable Treace Medical Concepts Insider Trades $580K In Company Stock Benzinga -5.51%
Nov-09-21 04:05PM	Treace Announces Participation in the Stifel 2021 Virtual Healthcare Conference GlobeNewswire
Nov-05-21 10:01AM	Treace Medical Concepts, Inc. (TMCI) Q3 2021 Earnings Call Transcript Motley Fool
Nov-04-21 04:05PM	Treace Medical Concepts Reports Third Quarter 2021 Financial Results GlobeNewswire
Oct-21-21 04:15PM	Treace Announces Grant of Additional U.S. Patent on Instrumented Bunion Correction GlobeNewswire -18.40%
Oct-14-21 04:15PM	Treace to Report Third Quarter 2021 Financial Results on November 4, 2021 GlobeNewswire +6.03%
Oct-04-21 08:00AM	Treace Medical Concepts Appoints New Directors GlobeNewswire -5.39%
Oct-01-21 08:00AM	Treace Announces First Patient Treated in Mini3D Lapiplasty® Clinical Study GlobeNewswire
Sep-23-21 04:15PM	Treace Announces New ALIGN3D Data at the 2021 AOFAS Annual Meeting GlobeNewswire
Sep-13-21 04:57PM	Treace Announces Launch of Adductoplasty Instrumented Midfoot Correction System GlobeNewswire
Sep-02-21 04:05PM	Treace Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference GlobeNewswire
Sep-01-21 10:00AM	Treace Announces New Supportive ALIGN3D Data to be Presented at the 2021 AOFAS Annual Meeting GlobeNewswire +5.43%
Aug-08-21 02:30AM	Treace Medical Concepts, Inc. (TMCI) Q2 2021 Earnings Call Transcript Motley Fool
Aug-05-21 04:05PM	Treace Medical Concepts Reports Second Quarter 2021 Financial Results GlobeNewswire
Jul-27-21 04:05PM	Treace to Report Second Quarter 2021 Financial Results on August 5, 2021 GlobeNewswire
Jul-23-21 07:45AM	How Much Of Treace Medical Concepts, Inc. (NASDAQ:TMCI) Do Insiders Own? Simply Wall St.
May-25-21 04:05PM	Treace Medical Concepts Reports First Quarter 2021 Financial Results GlobeNewswire
02:15PM	Treace Medical Concepts Inc to Host Earnings Call ACCESSWIRE
May-19-21 01:30PM	Treace Announces Interim Results from ALIGN3D Clinical Study at ACFAS 2021 GlobeNewswire
May-18-21 08:00AM	Treace to Report First Quarter 2021 Financial Results on May 25, 2021 GlobeNewswire
May-12-21 08:00AM	Treace to Announce Interim Results from ALIGN3D at ACFAS 2021 GlobeNewswire -5.97%
Apr-23-21 12:07PM	Five Companies Began Trading on Friday Barrons.com
Apr-22-21 09:55PM	UPDATE - Treace Medical Concepts Announces Pricing of Upsized Initial Public Offering GlobeNewswire
09:00PM	Treace Medical Concepts Announces Pricing of Upsized Initial Public Offering GlobeNewswire

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision; and Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Owens Daniel E.	Chief Human Resources Officer	Mar 15	Option Exercise	7.03	6,250	43,925	37,164	Mar 17 09:00 PM
TIMBIE THOMAS E	Director	Mar 15	Sale	23.03	50,000	1,151,665	1,149,069	Mar 17 09:00 PM
Owens Daniel E.	Chief Human Resources Officer	Mar 15	Sale	22.87	6,250	142,956	30,914	Mar 17 09:00 PM
BAYS F BARRY	Director	Mar 14	Sale	23.25	9,400	218,533	1,263,483	Mar 15 09:00 PM
BAYS F BARRY	Director	Mar 13	Sale	24.15	9,400	226,997	1,272,883	Mar 15 09:00 PM
Treace John T.	Chief Executive Offer	Mar 09	Sale	24.41	2,075	50,651	5,539,380	Mar 10 09:00 PM
MOTT RICHARD W	Director	Mar 09	Sale	26.00	1,502	39,052	1,058,498	Mar 10 09:00 PM
Hair Mark	Chief Financial Officer	Mar 09	Sale	24.41	1,040	25,386	27,110	Mar 10 09:00 PM
Berutti Aaron	Sr. VP, Sales	Mar 09	Sale	24.41	733	17,893	13,042	Mar 10 09:00 PM
Scanlan Sean F.	Chief Innovation Officer	Mar 09	Sale	24.41	505	12,327	9,470	Mar 10 09:00 PM
Owens Daniel E.	Chief Human Resources Officer	Mar 09	Sale	24.41	411	10,033	10,289	Mar 10 09:00 PM
Elder Scot Michael	*See "Remarks"	Mar 09	Sale	24.41	177	4,321	22,421	Mar 10 09:00 PM
MOTT RICHARD W	Director	Mar 08	Sale	23.17	45,000	1,042,502	1,060,000	Mar 10 09:00 PM
MOTT RICHARD W	Director	Mar 01	Sale	21.35	50,000	1,067,545	1,105,000	Mar 03 09:00 PM
TREACE JAMES T	Director	Mar 01	Sale	21.36	12,684	270,930	961,441	Mar 02 09:00 PM
TREACE JAMES T	Director	Feb 28	Sale	21.54	37,316	803,787	974,125	Mar 02 09:00 PM
BAYS F BARRY	Director	Feb 22	Sale	21.97	9,400	206,535	1,282,283	Feb 23 09:00 PM
BAYS F BARRY	Director	Feb 21	Sale	21.74	9,400	204,352	1,291,683	Feb 23 09:00 PM
Scanlan Sean F.	Chief Innovation Officer	Feb 15	Option Exercise	0.10	25,000	2,500	34,975	Feb 17 09:00 PM
TIMBIE THOMAS E	Director	Feb 15	Sale	21.71	50,000	1,085,350	1,199,069	Feb 17 05:52 PM
Scanlan Sean F.	Chief Innovation Officer	Feb 15	Sale	21.69	25,000	542,235	9,975	Feb 17 09:00 PM
BAYS F BARRY	Director	Feb 08	Sale	21.70	27,731	601,901	1,301,083	Feb 09 09:00 PM
BAYS F BARRY	Director	Feb 07	Sale	23.00	8,800	202,367	1,328,814	Feb 09 09:00 PM
MOTT RICHARD W	Director	Feb 02	Sale	24.00	4,011	96,264	1,155,000	Feb 03 09:00 PM
TREACE JAMES T	Director	Jan 31	Sale	23.19	11,929	276,634	1,011,441	Feb 02 09:00 PM
MOTT RICHARD W	Director	Jan 30	Sale	23.25	90,989	2,115,171	1,159,011	Jan 30 06:30 PM
TREACE JAMES T	Director	Jan 30	Sale	23.20	38,071	883,092	1,023,370	Jan 30 06:35 PM
BAYS F BARRY	Director	Jan 25	Sale	25.40	27,722	704,099	1,337,614	Jan 26 09:13 PM
BAYS F BARRY	Director	Jan 24	Sale	26.03	25,921	674,744	1,365,336	Jan 26 09:13 PM
TIMBIE THOMAS E	Director	Jan 18	Sale	25.88	50,000	1,294,000	1,249,069	Jan 20 09:00 PM
MOTT RICHARD W	Director	Jan 17	Sale	26.00	11,014	286,377	1,250,000	Jan 19 09:00 PM
MOTT RICHARD W	Director	Jan 13	Sale	26.00	6,519	169,495	1,261,014	Jan 13 09:00 PM
Scanlan Sean F.	Chief Innovation Officer	Jan 12	Option Exercise	0.10	25,000	2,500	34,975	Jan 13 09:00 PM
BAYS F BARRY	Director	Jan 12	Sale	25.52	45,536	1,162,139	1,391,257	Jan 13 09:00 PM
MOTT RICHARD W	Director	Jan 12	Sale	26.00	42,467	1,104,167	1,267,533	Jan 13 09:00 PM
Scanlan Sean F.	Chief Innovation Officer	Jan 12	Sale	25.57	25,000	639,308	9,975	Jan 13 09:00 PM
BAYS F BARRY	Director	Jan 11	Sale	24.32	9,719	236,366	1,436,793	Jan 13 09:00 PM
MOTT RICHARD W	Director	Jan 09	Sale	24.00	10,444	250,677	1,310,000	Jan 09 09:00 PM
MOTT RICHARD W	Director	Jan 05	Sale	24.00	9,556	229,363	1,320,444	Jan 09 09:00 PM
MOTT RICHARD W	Director	Dec 30	Sale	22.67	75,000	1,700,422	1,330,000	Dec 30 09:00 PM
BAYS F BARRY	Director	Dec 20	Sale	23.24	9,414	218,777	1,481,333	Dec 21 09:00 PM
BAYS F BARRY	Director	Dec 19	Sale	22.86	9,067	207,264	1,490,747	Dec 21 09:00 PM
TIMBIE THOMAS E	Director	Dec 14	Sale	24.00	50,000	1,199,935	1,299,069	Dec 16 09:00 PM
TREACE JAMES T	Director	Dec 12	Sale	24.18	25,000	604,575	1,061,441	Dec 14 09:00 PM
BAYS F BARRY	Director	Dec 08	Sale	23.99	9,739	233,639	1,499,814	Dec 09 09:00 PM
BAYS F BARRY	Director	Dec 07	Sale	23.97	9,061	217,192	1,509,553	Dec 09 09:00 PM
Owens Daniel E.	Chief Human Resources Officer	Dec 02	Option Exercise	10.35	5,625	58,230	14,450	Dec 02 09:00 PM
Owens Daniel E.	Chief Human Resources Officer	Dec 02	Sale	25.00	5,625	140,625	10,700	Dec 02 09:00 PM
MOTT RICHARD W	Director	Dec 01	Sale	24.00	20,000	480,000	1,405,000	Dec 02 09:00 PM
MOTT RICHARD W	Director	Nov 30	Sale	21.90	75,000	1,642,800	1,425,000	Dec 02 09:00 PM
BAYS F BARRY	Director	Nov 29	Sale	22.18	9,400	208,464	1,518,614	Nov 30 09:00 PM
BAYS F BARRY	Director	Nov 28	Sale	22.09	9,400	207,665	1,528,014	Nov 30 09:00 PM
TIMBIE THOMAS E	Director	Nov 22	Sale	22.11	10,070	222,597	1,349,069	Nov 22 09:00 PM
Treace John T.	Chief Executive Offer	Nov 21	Buy	21.83	15,000	327,405	5,541,455	Nov 21 06:27 PM
Berutti Aaron	Sr. VP, Sales	Nov 21	Buy	21.86	1,825	39,894	13,775	Nov 21 06:32 PM
TIMBIE THOMAS E	Director	Nov 21	Sale	22.08	224	4,947	1,359,139	Nov 22 09:00 PM
TIMBIE THOMAS E	Director	Nov 18	Sale	22.70	39,706	901,371	1,359,363	Nov 22 09:00 PM
Treace John T.	Chief Executive Offer	Nov 17	Buy	21.67	10,000	216,714	5,526,455	Nov 17 05:55 PM
TIMBIE THOMAS E	Director	Nov 16	Sale	20.14	50,000	1,006,900	1,399,069	Nov 18 08:00 PM
Owens Daniel E.	Chief Human Resources Officer	Nov 15	Option Exercise	7.03	6,250	43,925	16,950	Nov 17 08:00 PM
Owens Daniel E.	Chief Human Resources Officer	Nov 15	Sale	20.38	6,250	127,371	10,700	Nov 17 08:00 PM
Scanlan Sean F.	SVP, Marketing	Nov 14	Option Exercise	0.10	25,000	2,500	34,975	Nov 16 08:00 PM
Scanlan Sean F.	SVP, Marketing	Nov 14	Sale	24.27	25,000	606,680	9,975	Nov 16 08:00 PM
BAYS F BARRY	Director	Nov 10	Sale	23.44	9,400	220,318	1,537,414	Nov 14 06:00 AM
BAYS F BARRY	Director	Nov 09	Sale	21.09	17,123	361,114	1,546,814	Nov 14 06:00 AM
MOTT RICHARD W	Director	Oct 31	Sale	23.57	95,000	2,238,932	1,500,000	Nov 01 07:00 PM
Elder Scot Michael	*See "Remarks"	Oct 26	Sale	23.46	613	14,381	18,862	Nov 02 08:53 AM
TREACE JAMES T	Director	Oct 20	Sale	23.02	8,742	201,236	1,086,441	Oct 21 08:00 PM
TREACE JAMES T	Director	Oct 19	Sale	22.80	41,258	940,584	1,095,183	Oct 21 08:00 PM
BAYS F BARRY	Director	Oct 19	Sale	22.75	26,262	597,409	1,563,937	Oct 20 06:39 PM
BAYS F BARRY	Director	Oct 18	Sale	24.02	25,428	610,781	1,590,199	Oct 20 06:39 PM
BAYS F BARRY	Director	Oct 06	Sale	23.19	13,500	313,052	1,615,627	Oct 07 06:01 PM
BAYS F BARRY	Director	Oct 05	Sale	22.57	16,274	367,272	1,629,127	Oct 07 06:01 PM
BAYS F BARRY	Director	Sep 28	Sale	23.03	23,068	531,210	1,645,401	Sep 29 06:00 PM
BAYS F BARRY	Director	Sep 27	Sale	22.36	14,424	322,492	1,668,469	Sep 29 06:00 PM
TREACE JAMES T	Director	Sep 14	Sale	23.03	50,000	1,151,416	1,136,441	Sep 16 09:00 PM
BAYS F BARRY	Director	Sep 14	Sale	23.53	48,657	1,144,719	1,648,072	Sep 15 06:00 PM
BAYS F BARRY	Director	Sep 13	Sale	22.46	19,700	442,391	1,696,729	Sep 15 06:00 PM
Owens Daniel E.	Chief Human Resources Officer	Sep 02	Option Exercise	7.02	1,500	10,531	12,200	Sep 02 08:00 PM
Owens Daniel E.	Chief Human Resources Officer	Sep 02	Sale	20.04	1,500	30,060	10,700	Sep 02 08:00 PM
Owens Daniel E.	Chief Human Resources Officer	Sep 01	Option Exercise	7.03	1,000	7,028	11,700	Sep 02 08:00 PM
Treace John T.	Chief Executive Offer	Sep 01	Buy	19.80	10,000	198,031	5,516,455	Sep 01 05:21 PM
Owens Daniel E.	Chief Human Resources Officer	Sep 01	Sale	19.50	1,000	19,502	10,700	Sep 02 08:00 PM
BAYS F BARRY	Director	Aug 30	Sale	20.15	3,800	76,570	1,716,429	Aug 31 05:52 PM
BAYS F BARRY	Director	Aug 29	Sale	20.10	8,064	162,066	1,720,229	Aug 31 05:52 PM
Treace John T.	Chief Executive Offer	Aug 26	Buy	20.95	21,491	450,342	5,506,455	Aug 29 09:00 AM
Treace John T.	Chief Executive Offer	Aug 24	Buy	18.92	509	9,632	5,484,964	Aug 24 07:23 PM
Treace John T.	Chief Executive Offer	Aug 23	Buy	18.72	28,000	524,124	5,484,455	Aug 24 07:23 PM
TREACE JAMES T	Director	Aug 18	Sale	19.09	34,046	649,938	1,186,441	Aug 19 08:00 PM
TREACE JAMES T	Director	Aug 17	Sale	19.54	15,954	311,741	1,220,487	Aug 19 08:00 PM
TIMBIE THOMAS E	Director	Aug 16	Sale	19.91	50,000	995,500	1,449,069	Aug 17 08:00 PM
Owens Daniel E.	Chief Human Resources Officer	Aug 15	Option Exercise	7.03	1,500	10,542	12,200	Aug 16 05:00 PM
Owens Daniel E.	Chief Human Resources Officer	Aug 15	Sale	20.00	1,500	30,000	10,700	Aug 16 05:00 PM
TIMBIE THOMAS E	Director	Aug 05	Sale	19.04	4,904	93,373	1,499,069	Aug 05 06:01 PM
TIMBIE THOMAS E	Director	Aug 04	Sale	18.56	48,217	894,724	1,503,973	Aug 05 06:01 PM
TIMBIE THOMAS E	Director	Aug 03	Sale	18.85	96,879	1,825,869	1,552,190	Aug 05 06:01 PM
Owens Daniel E.	Chief Human Resources Officer	Aug 01	Option Exercise	7.03	1,000	7,028	11,700	Aug 03 07:00 AM
Owens Daniel E.	Chief Human Resources Officer	Aug 01	Sale	16.89	1,000	16,890	10,700	Aug 03 07:00 AM
TREACE JAMES T	Director	Jul 19	Sale	16.11	20,239	326,093	1,236,441	Jul 20 07:18 PM
TREACE JAMES T	Director	Jul 18	Sale	16.09	13,961	224,578	1,256,680	Jul 20 07:18 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience